American Healthcare REIT (NYSE:AHR - Get Free Report) is expected to release its Q1 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $542.32 million for the quarter.
American Healthcare REIT Stock Performance
NYSE AHR traded up $0.06 on Tuesday, reaching $32.47. 197,423 shares of the company's stock traded hands, compared to its average volume of 1,786,410. The stock has a 50 day moving average price of $29.98 and a 200-day moving average price of $28.60. American Healthcare REIT has a fifty-two week low of $13.67 and a fifty-two week high of $32.80. The firm has a market cap of $5.12 billion, a price-to-earnings ratio of -67.67, a P/E/G ratio of 1.57 and a beta of 1.40. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37.
American Healthcare REIT Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, April 17th. Investors of record on Monday, March 31st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.08%. The ex-dividend date was Monday, March 31st. American Healthcare REIT's payout ratio is presently -370.37%.
Analyst Upgrades and Downgrades
AHR has been the subject of several recent research reports. Citigroup reaffirmed an "outperform" rating on shares of American Healthcare REIT in a report on Tuesday, March 4th. JMP Securities set a $35.00 price target on American Healthcare REIT in a report on Tuesday, March 4th. KeyCorp dropped their price objective on shares of American Healthcare REIT from $35.00 to $34.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Jefferies Financial Group began coverage on shares of American Healthcare REIT in a research note on Monday, April 28th. They set a "buy" rating and a $37.00 target price on the stock. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $34.00 price target on shares of American Healthcare REIT in a research note on Wednesday, March 19th. Eight analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $33.86.
View Our Latest Report on AHR
American Healthcare REIT Company Profile
(
Get Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Further Reading
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
